4-(acetylamino)benzeneacetic acid has been researched along with mirabegron in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwatsubo, T; Krauwinkel, W; Meijer, J; Miyashita, A; Nagata, M; Schaddelee, M; Sekiguchi, M; Suzuki, K; Takusagawa, S; Usui, T; van Gelderen, M; van Lier, JJ | 1 |
1 trial(s) available for 4-(acetylamino)benzeneacetic acid and mirabegron
Article | Year |
---|---|
Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.
Topics: Absorption; Acetanilides; Administration, Oral; Adrenergic beta-3 Receptor Agonists; Adult; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Feces; Humans; Male; Mass Spectrometry; Metabolic Clearance Rate; Molecular Structure; Receptors, Adrenergic, beta-3; Thiazoles; Young Adult | 2012 |